UK quietly restricted Covid medicine exports to EU
Around 100 medications banned from export amid criticism of EU vaccine threats
The government last year placed export restrictions on medicines that could be used to treat Covid-19, despite criticising the EU for considering its own controls on vaccines produced on the continent.
Exports of around 100 drugs that have been suggested as possible treatments were banned because they “are needed for UK patients”, Politico reports.
Analysis by the news site found that the government “imposed controls on the export of over 170 medicines to other countries” since March last year.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Two of the most recent additions to the list, added in November last year, were dabigatran etexilate, a blood thinner used on some coronavirus patients, and semaglutide, which doctors believe could help ease the impact of Covid-19 on patients’ hearts. The list also includes flu vaccines and a “host of medicines associated with intensive care and long periods of intubation”, the site adds
The Department of Health and Social Care said that medicines “manufactured and intended for markets abroad are not subject to the export restrictions”.
“We have restricted the exporting and hoarding [of] medicines that have been placed on the market in the UK for UK patients to ensure the uninterrupted supply for NHS patients,” it added. “If medicines in the UK may be needed by our patients, they should not be diverted to other countries for financial gain.”
Boris Johnson this week attacked the EU amid reports that the bloc was considering imposing export controls on the Pfizer Covid vaccine produced in Belgium. The prime minister said he strongly opposed “restrictions on the supply of drugs across borders” and “restrictions on vaccines or their ingredients across borders”.
The EU export restrictions were mooted after AstraZeneca said it would not be able to deliver on a “three-digit million-euro” contract to reserve 300 million vaccine doses to the bloc. The pharmaceutical giant’s CEO Pascal Soriot has moved to defend the company’s rollout of the vaccine in the EU, describing its member states as “aggravated” and “emotional”.
However, there are signs that relations are thawing. After a crisis meeting held yesterday, described by both as “constructive”, EU Health Minister Stella Kyriakides said the pair “will work with the company to find solutions and deliver vaccines rapidly”.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
'A wonky bureaucratic tweak has dramatically changed how Americans drive'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Will Aukus pact survive a second Trump presidency?
Today's Big Question US, UK and Australia seek to expand 'game-changer' defence partnership ahead of Republican's possible return to White House
By Sorcha Bradley, The Week UK Published
-
It's the economy, Sunak: has 'Rishession' halted Tory fightback?
Today's Big Question PM's pledge to deliver economic growth is 'in tatters' as stagnation and falling living standards threaten Tory election wipeout
By Harriet Marsden, The Week UK Published
-
Why your local council may be going bust
The Explainer Across England, local councils are suffering from grave financial problems
By The Week UK Published
-
Rishi Sunak and the right-wing press: heading for divorce?
Talking Point The Telegraph launches 'assault' on PM just as many Tory MPs are contemplating losing their seats
By Keumars Afifi-Sabet, The Week UK Published
-
How Finland's tightening presidential race could affect future of Europe
Under the radar Country has key geostrategic position along Nato's longest border with an increasingly belligerent Russia
By Harriet Marsden, The Week UK Published
-
'Making Russia pay for its aggression with its own assets has undeniable moral and practical appeal'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
How would a second Trump presidency affect Britain?
Today's Big Question Re-election of Republican frontrunner could threaten UK security, warns former head of secret service
By Harriet Marsden, The Week UK Published